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a b s t r a c t
Manganese superoxide dismutase, encoded by the Sod2 gene, is a ubiquitously expressed mitochondrial
antioxidant enzyme that is essential for mammalian life. Mice born with constitutive genetic knockout
of Sod2 do not survive the neonatal stage, which renders the longitudinal study of the biochemical and
metabolic effects of Sod2 loss difficult. However, multiple studies have demonstrated that tissue-
specific knockout of Sod2 in murine liver yields no observable gross pathology or injury to the mouse.
We hypothesized that Sod2 loss may have sub-pathologic effects on liver biology, including the
acquisition of reactive oxygen species-mediated mitochondrial DNA mutations. To evaluate this, we
established and verified a hepatocyte-specific knockout of Sod2 in C57/B6 mice using Cre-LoxP
recombination technology. We utilized deep sequencing to identify possible mutations in Sod2ÿ/ÿ
mitochondrial DNA as compared to wt, and both RT-PCR and traditional biochemical assays to evaluate
baseline differences in redox-sensitive pathways in Sod2ÿ/ÿ hepatocytes. Surprisingly, no mutations in
Sod2ÿ/ÿ mitochondrial DNA were detected despite measurable increases in dihydroethidium staining
in situ and concomitant decreases in complex II activity indicative of elevated superoxide in the
Sod2ÿ/ÿ hepatocytes. In contrast, numerous compensatory alterations in gene expression were identified
that suggest hepatocytes have a remarkable capacity to adapt and overcome the loss of Sod2 through
transcriptional means. Taken together, these results suggest that murine hepatocytes have a large reserve
capacity to cope with the presence of additional mitochondrial reactive oxygen species.
& 2013 The Authors. Published by Elsevier B.V.
Introduction
The liver is a highly metabolically active organ, and is heavily
dependent on mitochondrial energy production for appropriate
functionality. Hepatocytes thus require a high intrinsic capacity
for superoxide O2
dÿ
ÿ 
removal in the mitochondrial compartment
to mitigate free radical production from the electron transport
chain. Moreover, as part of the blood detoxification and filtration
system, hepatocytes encounter an enormous number of extrinsic
pro-oxidant species. Not surprisingly, reactive oxygen species (ROS)
have a demonstrable role in pathogenesis for a number of sig-
nificant liver diseases, including those associated with alcohol
intoxication, acetaminophen overdose, and hepatitis viral infection
[1–4]. It has additionally been demonstrated that both the iron
response pathway and the hypoxia-inducible factor pathway are
perturbed in the presence of pro-oxidant stress [5,6]. These findings
collectively underscore the importance of maintaining an appro-
priate redox balance in hepatocytes, and illustrate the potential
health benefits associated with further investigation in this area.
Manganese superoxide dismutase (SOD2) is the solitary mito-
chondrial superoxide dismutase, and is highly abundant in
mitochondrion-rich hepatocytes. Previously, multiple groups
have studied the effects of SOD2 loss in murine models. Non-
specific genetic deletion of the Sod2 locus was not an effective
method for study of liver biology, as it proved to be lethal in the
neonatal period. Pups born without functional SOD2 protein died
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within 3 weeks of birth from massive multisystem failure [7,8].
Subsequent use of the Cre-LoxP recombination system enabled
the tissue-specific deletion of Sod2 in murine hepatocytes, cir-
cumventing the neonatal lethality of the total-animal knockout.
To date, two studies have demonstrated that albumin-Cre-
mediated excision of Sod2 produces no overt liver pathology by
traditional histology or any measurement in markers indicative of
oxidative stress [9,10]. A third study, published by Lenart et al,
excised Sod2 at an earlier developmental stage with an a-
fetoprotein-Cre, and reported distinct changes in hepatocyte
physiology and disrupted zonal patterns of gene expression in
the murine liver [11]. From these prior results, it appears clear
that SOD2 plays an important role in liver development, because
albumin-Cre mediates post-natal excision of the Sod2 locus.
However, we remained intrigued by the absence of overt liver
pathology in the absence of SOD2 protein in murine hepatocytes,
given both the intrinsic and extrinsic pro-oxidant stresses that the
liver is subjected to on a regular basis. We hypothesized that sub-
pathologic effects, such as oxidative damage to mitochondrial
DNA, may be accumulating in these hepatocytes, without leading
to overt organ system damage.
To address this, we utilized Cre-LoxP technology with an
albumin-Cre-mediated knockout to generate Sod2ÿ/ÿ hepato-
cytes in C57/B6 mice. Confirming previous studies with this
model, these mice did not suffer any adverse pathologic con-
sequences from the loss of SOD2 mRNA transcript, protein, or
activity in hepatocytes. To evaluate mitochondrial DNA integrity,
we deep sequenced mitochondrial DNA from both Sod2ÿ/ÿ
animals and wt controls. We additionally investigated a repre-
sentative series of both antioxidant and iron response pathways
via RT-PCR, western blotting, and biochemical assays to identify
potential compensatory mechanisms to account for the lack of
gross pathology. Our results demonstrate that the loss of mito-
chondrial superoxide dismutase alone is an insufficient stimulus
to promote an accumulation of mitochondrial DNA mutations in
murine hepatocytes, secondary to a remarkable reserve capacity
of hepatocytes to accommodate enhanced pro-oxidant
production.
Materials and methods
Animal colony maintenance and use
Mice homozygous for the loxP-flanked Sod2 allele (B6.Cg-
Sod2tm1, henceforth Sod2L/L) were obtained from Dr. Takuji Shir-
asawa of the Tokyo Metropolitan Institute of Gerontology and
maintained as previously described [12]. B6.Cg-Tg-AlbCre21Mgn/J
(henceforth Alb-Cre) animals were donated by Dr. Curt Sigmund
(The University of Iowa) and were previously described [13,14].
Experimental animals were generated using an F3 breeding
scheme and littermate controls were utilized for all studies.
Genotyping was accomplished with DNA isolated from tail snips
taken at the time of weaning, with the following primer
sequences: Sod2-P1:50-CGAGGGGCATCTAGTGGAGAAG-30, Sod2-
P2: 50-TTAGGGCTCAGGTTTGTCCAGAA-30, Cre-F: 50-CGATGCAAC-
GAGTGATGAGGT-30, Cre-R: 50-GTGAAACAGCATTGCTGTCACTT-30.
Animals were cared for and handled in accordance with the
appropriate Institutional Animal Care and Use Committee guide-
lines at the University of Iowa. Experimental animals were
sacrificed using CO2 asphyxiation followed by cervical dislocation.
All animals were 10 weeks of age unless otherwise noted. Livers
were dissected out, washed in ice-cold PBS, and weighed before
individual portions were cut and processed for different experi-
mental analysis. Portions that were unused at the time of harvest
were snap frozen in liquid nitrogen and stored at ÿ80 1C.
Histological analysis and immunohistochemistry
Samples used for histological analysis of liver pathology were
placed in 10% neutral buffered formalin for fixation and preserva-
tion. Samples were embedded in paraffin, sectioned, and stained
at the Comparative Histopathology Core Facility at the University
of Iowa, under the direction of Dr. David Meyerholz, DVM, PhD,
and Dr. Alicia Olivier, DVM, PhD. Immunohistochemical analysis
for the presence of SOD2 in liver sections was accomplished using
SOD2 antibody (AB10346, Millipore, Billerica, MA, USA).
Quantitative RT-PCR analysis of gene expression
Snap-frozen liver pieces were ground in liquid nitrogen using a
mortar and pestle, and a portion of the pulverized liver material
was used for RNA isolation by the TRIZOL method, followed by
quantitation on a Nanodrop ND-1000. One microgram of total
RNA was converted to cDNA using the cDNA archive kit (Applied
Biosystems). Quantitative real-time PCR was then performed
using 10 ng total of cDNA with an ABI Fast 7500 system thermal
cycler running in standard mode. Both SYBR green and Taqman
primer probe technologies were utilized for gene analysis as
specified in the text. Fold changes were calculated using the
DDCt method, using the 18S ribosomal RNA as a control and
Sod2L/L animals as references.
Protein immunoblotting
Snap-frozen liver pieces were prepared as above with a mortar
and pestle under liquid nitrogen and suspended in a minimal
volume of standard RIPA buffer supplemented with protease
inhibitors (Product P8340, Sigma Aldrich), 100 mM PMSF, 1 mM
sodium vanadate, 1 mM sodium fluoride, 1 mM DTT. Samples
were snap frozen in liquid nitrogen and thawed 3 times, and
cellular debris was pelleted by centrifugation at 20,000g for
10 min at 4 1C. Protein concentration was determined by the
Bradford method, and equivalent protein amounts were run on
10% SDS-PAGE gels before transfer to nitrocellulose. Blots were
probed using primary antibodies followed by HRP-conjugated
secondary antibodies with appropriate species specificity. Anti-
bodies used for these analyses include SOD2 (Millipore), SDHB
(Abcam), HMOX1 (Abcam), ALAS2 (Abcam), TFR1 (Abcam), FTH
(Abcam), and b-actin (Developmental Studies Hybridoma Bank,
The University of Iowa, Iowa City). Quantitation of blots was done
utilizing ImageJ software.
Antioxidant enzyme activity assays
SOD activity was measured in liver homogenates using the
assay developed by Spitz and Oberley [15]. SOD2 activity was
measured in the presence of 5 mM sodium cyanide to inhibit
SOD1 activity. Total GSH levels were determined using a recycling
assay that spectrophotometrically measures dTNB reduction to
TNB in the presence of glutathione reductase according to proto-
cols described by Griffith [16] and Anderson [17]. Glutathione
peroxidase activity was measured by monitoring NADPH oxida-
tion in the presence of reduced glutathione, glutathione reduc-
tase, and either H2O2 or cumene hydroperoxide [18]. All sample
measurements were normalized to protein content as evaluated
by the Bradford method (enzyme activities) or the BCA method
(total glutathione). All statistics were calculated using Microsoft
Excel.
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Dihydroethidium staining of frozen sections
Samples were analyzed in a method adapted from use in
cardiovascular studies [19–21]. Briefly, freshly dissected livers
were frozen in OCT medium, and 10 mm sections were cut and
placed on slides. In a dark room, several drops of 5 mM dihy-
droethidium (DHE) and 10 nM Mitotracker Green (Life Technol-
ogies) were placed on tissue sections and slides were incubated in
a humidified chamber for 30 min at 37 1C. Slides were carefully
rinsed with PBS, coverslipped, and examined with a Zeiss 710
confocal microscope with an excitation wavelength of 544 nm
and an emission wavelength of 612 nm. Images were converted
into TIFF format using ImageJ.
Mitochondrial complex II activity assay
Freshly isolated livers were dissociated in ice-cold mannitol
homogenization buffer (0.3 M mannitol, 0.006 M KH2PO4,
0.014 M K2HPO4) using a Dounce homogenizer with 10 strokes
of the loose and then 10 strokes of the tight pestle. Homogenates
were spun at 600 g for 10 min at 4 1C to pellet nuclear and cellular
debris. The resultant supernatants were spun at 5000 g for 10 min
at 4 1C to crudely pellet mitochondria. Mitochondria were washed
once and resuspended in 1 ml of ice-cold assay buffer (0.3 M
mannitol, 0.006 M KH2PO4, 0.014 M K2HPO4, 0.01 M KCL, 0.005 M
MgCl2, pH 6.2). Protein was quantified using the Bradford method.
A total of 50 mg of protein were used per assay, and antimycin A
(1 mg/ml), sodium azide (10 mM), and rotenone (1 mg/ml) were
utilized to block other complex respiration. Complex II activity
was calculated by observing the reduction of dichloroindophenol
(DCIP) at 600 nm following the addition of 5 mM succinate to the
reaction volume. The reaction was followed on a Tecan Infinite
200 PRO microplate spectrophotometer and final complex II
activity was calculated using a molar extinction coefficient for
DCIP of 19100. All statistical analysis was accomplished using
Microsoft Excel.
Mitochondrial complex I respiration assay
Complex I activity was assessed using a Seahorse XF96 Extra-
cellular Flux Analyzer, following the protocol established by Rogers
et al. [22]. Mitochondrial fractions were isolated as described and
4 ug of total mitochondrial isolate was loaded per well in the XF96
plate format. Plates were spun at 4 1C at 2000 g for 20 min to affix
mitochondria to the wells. The assay was run in the presence of
5 mM pyruvate and 5mMmalate, with sequential injections of FCCP
and Antimycin A to final concentrations of 4 mM apiece. A minimum
of 5 technical replicates was used for each mitochondrial isolation.
Statistical analysis was accomplished using Microsoft Excel.
Mitochondrial genomic sequencing
Mitochondrial DNA was prepared for sequencing according to
the Ion Torrent Ion Fragment Library Kit protocol, with minor
modifications. DNA was sonicated to fragments between 150 and
200 bp and confirmed on a 1% agarose gel. Fragmented DNA was
then subjected to the end-repair reaction, followed by ligation of
sequencing adapters. The adapter-ligated library was size-
separated on a 2% agarose gel and library products between the
sizes of 170 bp and 225 bp were isolated using a modified
siliconized glass wool extraction method and purified using the
Agencourt AMPure XP PCR purification kit (Beckman Coulter,
Beverly, MA). The purified library was subjected to a nick-
translation and amplification for 5 cycles, quantitated on an
Agilent High Sensitivity DNA chip, diluted to 8.4107 mole-
cules/ml, and 5 ml was added to the OneTouch emulsion PCR
reaction. Beads with template were isolated using the Ion Torrent
OneTouch ES and loaded on to a 316 sequencing chip. Sequencing
was performed according to manufacturer’s protocols and the
resulting data downloaded as a FASTQ file. Sequences were
loaded into SoftGenetic’s NextGene software version 2.0.0 and
filtered for length (minimum 25 called bases) and quality (median
Q12 or higher, trim after 1 base less than Q12). Filtered reads
Fig. 1. Establishment of Sod2 hepatocyte-specific knockout. (A) Western blot for SOD2 demonstrating loss of SOD2 protein in Sod2ÿ /ÿ (KO) livers compared to Sod2L/L
(Con) livers. (B and C) Quantification of significant reduction in Sod2message (B) and SOD2 activity (C) in KO livers compared to control. (D) Immunohistochemical staining
for SOD2 demonstrates pan-hepatocellular knockout in Sod2ÿ/ÿ livers compared to control. (E) Representative in situ DHE staining demonstrating enhanced nuclear
positivity in Sod2ÿ/ÿ livers compared to control.
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were then aligned to mouse mitochondrial sequence from assem-
bly NCBI37/mm9 and examined for variants.
Results and discussion
Establishment of hepatocyte-specific loss of Sod2 in conditional
knockout mice
LoxP-flanked mice harboring albumin-Cre by PCR analysis were
identified as potential hepatocyte-specific Sod2ÿ/ÿ candidates. This
was verified by assaying liver homogenates in both Sod2L/L and
Sod2ÿ/ÿ animals for evidence of Sod2 expression (Fig. 1A–C). Sod2ÿ/
ÿ animals had a significant reduction in SOD2 protein, Sod2 mRNA,
and SOD2 activity when compared with Sod2L/L littermate controls.
In situ immunohistochemical analysis for SOD2 demonstrated near
total pan-hepatocellular reduction in SOD2 protein in Sod2ÿ/ÿ livers
compared to Sod2L/L livers, with residual signal remaining in both
endothelial cells and occasional Kupffer cells (Fig. 1D). In situ
staining with DHE was utilized to evaluate the production of pro-
oxidant species in frozen sections. Sod2ÿ/ÿ sections demonstrated
enhanced DHE positivity with a high degree of nuclear localization
when compared with Sod2L/L control mice, suggesting increased
production of pro-oxidant species (Fig. 1E). Notably, no overt
structural or other phenotypic differences were seen when compar-
ing Sod2ÿ/ÿ livers to Sod2L/L livers using a variety of other
histochemical techniques, including Masson’s Trichrome for aber-
rant collagen deposition, hematoxylin and eosin staining for basic
structural abnormalities, or Prussian blue for iron accumulation
(data not shown). Additionally, no differences in overall mitochon-
drial number were observed following quantitative morphometric
analysis using transmission electron microscopy (data not shown).
Collectively, these results confirm both a successful knockout of
Sod2 in murine hepatocytes and affirm the results from previous
studies using albumin-Cre as a driver for Sod2 excision.
Evaluation of complex I and complex II in Sod2ÿ /ÿ hepatocytes
To address the hypothesis that SOD2 loss in murine hepato-
cytes might be promoting sub-pathological damage accumula-
tion, several aspects of mitochondrial biology were evaluated.
Complex I activity was evaluated using isolated mitochondria
with a Seahorse XF96 extracellular flux analyzer, and demon-
strated no differences between Sod2L/L and Sod2ÿ/ÿ mitochondria
(Fig. 2A). In contrast, complex II activity was markedly different
between Sod2L/L and Sod2ÿ/ÿ mitochondria. Sod2ÿ/ÿ samples had
an average activity of 0.76 nm DCIP reduced mg proteinÿ1 sÿ1
compared to 2.31 nm DCIP reduced mg proteinÿ1 sÿ1 in Sod2L/L
samples, demonstrating a significant reduction (p¼0.004) in
overall complex II activity. This was accompanied by a concomi-
tant loss of immunoreactive succinate dehydrogenase subunit B
(SDHB), which harbors the critical iron–sulfur core of complex II
and is known to be sensitive to perturbation by superoxide
(Fig. 2B). This observation, coupled with the enhanced DHE
positivity seen in Sod2ÿ/ÿ frozen sections (Fig. 1E), strongly
Fig. 2. Measurement of mitochondrial complex activity and mtDNA integrity. (A) Complex I activity assay as run on Seahorse extracellular flux analyzer, with no
significant differences noted between KO (empty squares) and control (filled squares) samples (n¼3 mice per group). (B) Complex II activity assay demonstrating
significant reduction in complex II in Sod2ÿ /ÿ samples compared to control, with an accompanying reduction in SDHB protein on western blotting. (C) Graph of sequencing
coverage for Sod2þ /þ and Sod2ÿ/ÿ mitochondrial genomes. The number of reads at each position of the mitochondrial genome is shown for forward (red) and reverse
(blue) reads. Below: sequence variant at position 4539 in the mitochondrial genome. Screen capture showing representative reads from the second sequencing run of the
Sod2ÿ /ÿ mitochondrial genome aligned to reference (top sequence), the variant is shown as a C/T transition just below the reference sequence. Reads containing the
variant are highlighted in blue. Mitochondrial genome position is indicated above the reference sequence. (For interpretation of the references to color in this figure legend,
the reader is referred to the web version of this article.)
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suggest that the loss of Sod2 is promoting an increase in super-
oxide in Sod2ÿ/ÿ mitochondria.
Mitochondrial genomic sequencing
It is commonly accepted that mitochondrial DNA (mtDNA) is
more susceptible to oxidative modification than its nuclear
counterpart, due to both its environment in the redox active
mitochondrial matrix and the lack of involvement with histones
[23]. We thus hypothesized that the enhanced pro-oxidant
production in the mitochondrial compartment would lead to an
accumulation of oxidative damage to mtDNA. Mitochondrial DNA
from the livers of 10-week Sod2L/L and Sod2ÿ/ÿ mice was
subjected to deep sequencing to determine if any mutations were
accumulating in Sod2ÿ/ÿ mice (Fig. 2C). MtDNA sequence was
compared to reference sequence (NCBI37/mm9 assembly) for all
sequencing runs. In both the Sod2þ /þ and Sod2ÿ/ÿ samples a
variant (T4C) was found at position 4539 within the NADH
dehydrogenase subunit 2 sequence that changes an isoleucine to
threonine (Fig. 2C). Based on its presence in both Sod2ÿ/ÿ and
SodL/L sequences, this variant appears unrelated to SOD status. In
both Sod2ÿ/ÿ sequencing runs a variant (C4T) was found at
position 11828 within the NADH dehydrogenase subunit 5 that is
synonymous. There were insufficient reads in the wild type
sequence to confirm presence of the position 11828 variant in
the wild type mouse. Otherwise, no mutations were found in the
mitochondrial DNA of the SOD KOÿ/ÿ mouse’s mitochondrial
DNA relevant to the wild type sample. This was a remarkable
result—despite being essentially devoid of SOD activity and thus
exposed to elevated levels of pro-oxidant production sufficient to
promote biochemical defects, mtDNA integrity was preserved in
Sod2ÿ/ÿ hepatocytes and indistinguishable from normal hepato-
cytes. We thus hypothesized that a compensatory mechanism
was being implemented by Sod2ÿ/ÿ hepatocytes to enable them
to escape damage both to liver parenchyma and mtDNA.
Gene expression and pathway analysis
To initially address possible compensatory mechanisms at play
in Sod2ÿ/ÿ hepatocytes, we designed a custom quantitative RT-
PCR array to examine a variety of distinct genes chosen for their
importance in several critical redox systems. To provide robust
results for these experiments, template cDNA was pooled from 9
Sod2ÿ/ÿ and 9 Sod2L/L livers for group comparison. These animals
ranged from 65 to 87 weeks and had genotypes confirmed based
on Sod2 mRNA expression. Analysis demonstrated that 13 of the
44 genes on the array had at least a twofold difference in
expression based on Sod2 status (Fig. 3A). Critically, these genes
fell into several pathways, including those involved in iron
homeostasis such as heme oxygenase (Hmox1), ferritin light chain
1 (Ftl1), and ferrocheletase (Fech); several involved in antioxidant
response pathways such as Cu/Zn superoxide dismutase (Sod1),
Fig. 3. Compensatory mechanisms in Sod2ÿ /ÿ hepatocytes. (A) Results from gene array detailing 13 genes with greater than twofold expression difference in Sod2ÿ /ÿ
compared with control. Differences are derived from pooled populations of 9 mice per group. (B) Representative iron homeostasis genes are altered in Sod2ÿ /ÿ
hepatocytes. HMOX1—heme oxygenase 1, ALAS2—aminolevulinic acid synthase 2, TFR1—transferrin receptor 1, FTH—ferritin heavy chain. Numbers above blots indicate
quantitation using ImageJ software. (C) SOD1 activity assay demonstrating elevated SOD1 activity in Sod2ÿ/ÿ liver homogenates compared to control. (D) Total GSH is
slightly elevated in Sod2ÿ /ÿ liver homogenates compared to control. (E) Sod2ÿ/ÿ liver homogenates have increased selenium-dependent (black bar), selenium
independent (gray partition), and total GPx (overall height) compared to control. Results in (C), (D), and (E) are not statistically significant.
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peroxiredoxin 1 (Prdx1), thioredoxin 2 (Txn2), and glutathione
synthase (Gss); and others involved in other aspects of liver
biology such as deleted in malignant brain tumors 1 (Dmbt1).
Notably, Sdhb transcript was elevated in Sod2ÿ/ÿ hepatocytes,
suggesting a compensatory transcriptional upregulation second-
ary to the loss of SDHB protein established in Fig. 2B.
To evaluate the downstream effects of these transcriptionally
up-regulated genes several biochemical assays were utilized.
Using the results of the expression array as a guide, several iron
homeostasis elements were probed using western blotting. These
genes all are regulated at the post-transcriptional level through
the iron response protein system, which is sensitive to both free
iron levels and oxidative modification. Tellingly, HMOX1, amino-
levulinic acid synthase 2 (ALAS2), and ferritin heavy chain (FTH)
were all upregulated at the protein level to at least some degree in
response to Sod2 loss, suggesting that Sod2ÿ/ÿ hepatocytes are
actively engaging in a redistribution of iron (Fig. 3B).
To test the contribution of representative antioxidant response
pathways, several elements were examined. SOD1, though predo-
minantly localized to the cytoplasm, does reside in the intermem-
brane space of mitochondria [24] and could contribute to
mitochondrial protection. Accordingly, a small increase of 56 U/mg
was seen in SOD1 activity in Sod2ÿ/ÿ hepatocytes, though this was
not statistically significant (Fig. 3C). As multiple pathways in the
array analysis utilized glutathione, total GSH was measured in both
Sod2ÿ/ÿ and Sod2L/L samples. Sod2ÿ/ÿ samples contained an
average of 43.2 nmoles GSH/mg protein, whereas Sod2L/L samples
contained an average of 39.8 nmoles GSH/mg protein (Fig. 3D).
These same samples were additionally assayed for glutathione
peroxidase (GPx) activity. Again, small but statistically not signifi-
cant increases were seen in Sod2ÿ/ÿ hepatocytes in both selenium-
dependent (p¼0.07) and selenium-independent GPx activities as
well as total GPx activity (Fig. 3E). While none of these results
reached statistical significance, obvious trends in multiple different
assays spanning multiple redox pathways were seen. The likelihood
of these subtle results being randomly aligned in this way is slim,
especially given the diverse approaches taken to measure them.
Conclusions
Previous studies have demonstrated that Sod2ÿ/ÿ murine livers
suffer no observable pathologic damage at baseline. We hypothesized
that sub-pathologic damage, primarily in the form oxidative damage
to mtDNA, may be accumulating in these animals without reaching a
threshold for overt pathology. Surprisingly, this was not the case;
Sod2ÿ/ÿ liver mtDNA was qualitatively indistinguishable from Sod2L/L
liver mtDNA at 10 weeks of age, suggesting that Sod2ÿ/ÿ hepatocytes
are engaging in a significant compensatory effort to overcome
measurable increases in pro-oxidant production. Here, we demon-
strated that a constellation of subtle changes in redox biology path-
ways is indeed taking place in Sod2ÿ/ÿ hepatocytes, with the end
result being a functional murine liver with no evidence of microscopic
damage. The Sod2ÿ/ÿ murine liver thus represents a tremendous
model for evaluation of the reserve capacity of hepatocytes to deal
with exogenous pro-oxidant stress. Continued evaluation of this
model may yield important insights into further hepatoprotective
mechanisms that could be extended to clinical situations in humans.
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